Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043719 · ClinicalTrials.gov registry record · Phase 3
Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women
A Phase 3 study, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT00043719 is a Phase 3 study that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 200 participants.
The verdict
NCT00043719, a Phase 3 study, has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
Osteopenia and osteoporosis cause thinning of bone tissue and loss of bone density over time. The purpose of this study is to determine the safety and effectiveness of nitroglycerin ointment for the treatment of osteopenia in postmenopausal women. Study hypothesis: On average, participants in the base therapy cohort who receive placebo ointment control and calcium/vitamin D will lose more bone density than participants in the nitroglycerin cohort over the 36-month period.
Interventions
- DRUG Nitroglycerin ointment
- DRUG Calcium supplement with vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-07 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)93 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00043719
The ClinicalTrials.gov registry entry for NCT00043719 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nitroglycerin ointment is the first listed.
NCT00043719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00043719 about?
NCT00043719 is a clinical study titled "Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women". Osteopenia and osteoporosis cause thinning of bone tissue and loss of bone density over time. The purpose of this study is to determine the safety and effectiveness of nitroglycerin ointment for the treatment of osteopenia in postmenopausal women. Study hypothesis: On average, participants in the b...
What is the current status of trial NCT00043719?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2002-07. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00043719?
The interventions under investigation include: Nitroglycerin ointment (DRUG), Calcium supplement with vitamin D (DRUG).
Who is sponsoring clinical trial NCT00043719?
This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.